Search Within

Michael Morris

Formats
  1. Meeting Abstract (273)
  2. Journal Article (266)
  3. Review (19)
  4. Book Section (6)
  5. Editorial (6)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Miscellaneous (2)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (580)
  2. Genitourinary Oncology Service (580)
  3. Solid Tumor Oncology Division (580)
  4. Radiology, Department of (163)
  5. GSK Faculty (161)
  6. Molecular Imaging and Therapy Service (140)

More Groups

People
  1. Howard Scher (217)
  2. Steven Larson (93)
  3. Susan Slovin (90)
  4. Dana Rathkopf (79)
  5. Daniel Danila (54)
  6. Glenn Heller (54)

More People

Years
  1. 2025 (21)
  2. 2024 (50)
  3. 2023 (40)
  4. 2022 (50)
  5. 2021 (42)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (238)
  2. Journal of Nuclear Medicine (43)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (30)
  5. Cancer (18)
  6. European Urology (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (248)
  2. American Association for Cancer Research (43)
  3. Society of Nuclear Medicine (43)
  4. Oxford University Press (41)
  5. Elsevier Science, Inc. (39)
  6. Elsevier Inc. (27)

More Publishers

Results (580)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II, nonrandomized open trial assessing pain efficacy with radium-223 in symptomatic metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D.; Tagawa, S.; Moryl, N.; Milowsky, M.; Heller, G.; Osborne, J.; Rathkopf, D.; Basch, E.; Pandit-Taskar, N.; Morris, M. J.
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer
    Journal Article

    Sartor, O.; de Bono, J.; Chi, K. N.; Fizazi, K.; Herrmann, K.; Rahbar, K.; Tagawa, S. T.; Nordquist, L. T.; Vaishampayan, N.; El-Haddad, G.; more...
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • Phase 3 randomized controlled trial of androgen deprivation therapy with or without docetaxel in high-risk biochemically recurrent prostate cancer after surgery (TAX3503)
    Journal Article

    Morris, M. J.; Mota, J. M.; Lacuna, K.; Hilden, P.; Gleave, M.; Carducci, M. A.; Saad, F.; Cohn, E. D.; Filipenko, J.; Heller, G.; more...
    European Urology Oncology (2021)

    Fulltext@MSK | Save
  • A phase Ib study of atezolizumab with radium-223 dichloride in men with metastatic castration-resistant prostate cancer
    Journal Article

    Fong, L.; Morris, M. J.; Sartor, O.; Higano, C. S.; Pagliaro, L.; Alva, A.; Appleman, L. J.; Tan, W.; Vaishampayan, U.; Porcu, R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer
    Meeting Abstract

    Hirani, R.; Nandakumar, S.; Kalidindi, T.; Fidele, D.; Rajanala, H.; Mazzu, Y.; Yoshikawa, Y.; Jehane, L.; Lee, G. S. M.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Baseline testosterone levels in men with clinically localized high-risk prostate cancer treated with radical prostatectomy with or without neoadjuvant chemohormonal therapy (Alliance)
    Journal Article

    Eastham, J. A.; Heller, G.; Hillman, D. W.; Hahn, O. M.; Parsons, J. K.; Mohler, J. L.; Small, E. J.; Morris, M.
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Diagnostic performance of (18)F-DCFPyL-PET/CT in men with biochemically recurrent prostate cancer: Results from the CONDOR phase III, multicenter study
    Journal Article

    Morris, M. J.; Rowe, S. P.; Gorin, M. A.; Saperstein, L.; Pouliot, F.; Josephson, D.; Wong, J. Y. C.; Pantel, A. R.; Cho, S. Y.; Gage, K. L.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Genitourinary medical oncology expert opinion survey regarding treatment management in the COVID-19 pandemic
    Journal Article

    Sarfaty, M.; Feldman, D. R.; Morris, M. J.; Motzer, R. J.; Rathkopf, D. E.; Regazzi, A. M.; Iyer, G.; Voss, M. H.; Bajorin, D. F.; Rosenberg, J. E.
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • Reply by authors
    Correspondence

    Pienta, K. J.; Gorin, M. A.; Rowe, S. P.; Carroll, P. R.; Pouliot, F.; Probst, S.; Saperstein, L.; Preston, M. A.; Alva, A. S.; Patnaik, A.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Inferences about drug safety in phase III trials in oncology: Examples from advanced prostate cancer
    Journal Article

    Drago, J. Z.; Gönen, M.; Thanarajasingam, G.; Sacks, C. A.; Morris, M. J.; Kantoff, P. W.; Stopsack, K. H.
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save